Glucagon-Like Peptide-1 Receptor Agonist Prevented the Progression of Hepatocellular Carcinoma in a Mouse Model of Nonalcoholic Steatohepatitis

Glucagon-like peptide-1 (GLP-1) receptor agonists are used to treat diabetes, but their effects on nonalcoholic steatohepatitis (NASH) and the development of hepatocellular carcinoma (HCC) remain unclear. In this study, mice with streptozotocin- and high-fat diet-induced diabetes and NASH were subcu...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Int J Mol Sci
Main Authors: Kojima, Motoyasu, Takahashi, Hirokazu, Kuwashiro, Takuya, Tanaka, Kenichi, Mori, Hitoe, Ozaki, Iwata, Kitajima, Yoichiro, Matsuda, Yayoi, Ashida, Kenji, Eguchi, Yuichiro, Anzai, Keizo
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2020
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7460814/
https://ncbi.nlm.nih.gov/pubmed/32785012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21165722
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki